These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
24. [Quantitative rheographic study of the effects of a new drug combination: raubasine/dihydroergocristine]. Henriet M; Jacquy J; Noel G Brux Med; 1974 Dec; 54(12):743-5. PubMed ID: 4215548 [No Abstract] [Full Text] [Related]
25. [Treatment of ischemic brain lesions]. Eichhorn O Med Welt; 1969 Oct; 42():2314-8. PubMed ID: 4982284 [No Abstract] [Full Text] [Related]
26. [Pharmacology of brain circulation and clinical extrapolations. An experimental study of the circulatory and metabolic effects of Hydrosarpan 711]. Cahn J; Herold M; Borzeix MG Sem Hop Ther; 1974 Dec; 50(10):671-82. PubMed ID: 4465918 [No Abstract] [Full Text] [Related]
27. [Calcium antagonists and cerebrovascular circulation]. De Gregorio C Clin Ter; 1987 Oct; 123(1):41-50. PubMed ID: 2972466 [No Abstract] [Full Text] [Related]
28. [On the demonstration of drug effects on the brain circulation]. Klein K Med Welt; 1967 Sep; 35():2021-5. PubMed ID: 5595992 [No Abstract] [Full Text] [Related]
29. [Future treatment of stroke. Brain damage in stroke can be reduced by drugs]. Siesjö BK Lakartidningen; 1993 Sep; 90(36):2958, 2962-4. PubMed ID: 8366724 [No Abstract] [Full Text] [Related]
30. [Effect of uphyllin on cerebral and peripheral blood flow in strokes (rheoencephalographic and oscillographic studies)]. Khadzhiev D Zh Nevropatol Psikhiatr Im S S Korsakova; 1967; 67(4):538-42. PubMed ID: 5596940 [No Abstract] [Full Text] [Related]
31. [Studies on the effect of a new coronary vessel dilating substance, carbochromen, on the blood circulation and metabolism of the brain]. Yamaoka S; Okada T; Kawamura M; Saito Y Med Welt; 1968 Mar; 12():764-70. PubMed ID: 5728935 [No Abstract] [Full Text] [Related]
32. [On the role of vincamine in the therapy of cerebrovascular diseases and impairment of cerebral function (author's transl)]. Witzmann HK; Blechacz W Arzneimittelforschung; 1977; 27(6a):1238-47. PubMed ID: 332190 [No Abstract] [Full Text] [Related]
33. [Effect of a combination of vasoactive substances on metabolism and the rheoencephalogram]. Hammerl H; Kränzl C; Nebosis G; Pichler O; Studlar M Wien Klin Wochenschr; 1973 Sep; 123(37):533-8. PubMed ID: 4148002 [No Abstract] [Full Text] [Related]
34. [The current drug treatment of patients with cerebral venous dystonia]. Orzheshkovskiĭ VV Lik Sprava; 1999 Jun; (4):40-4. PubMed ID: 10476639 [No Abstract] [Full Text] [Related]
36. Therapeutic experience with Stugeron. Abrányi I Ther Hung; 1973; 21(3-4):117-20. PubMed ID: 4806419 [No Abstract] [Full Text] [Related]
37. [Effect of drugs on cerebrovascular circulation with special regard to Hydergin]. Radielović P Lijec Vjesn; 1971; 93(11):1227-32. PubMed ID: 5005614 [No Abstract] [Full Text] [Related]
38. [Mental effects of Wallerox therapy in the aged]. Thomae H Med Klin; 1970 Jun; 65(23):1132-4. PubMed ID: 5000216 [No Abstract] [Full Text] [Related]
39. [The effect of isradipine on the central and cerebral hemodynamics of patients with circulatory encephalopathy and hypertension]. Lepakhin VK; Ivleva AIa; Romashova MF; Udotova SA; Zubovskiĭ LG Eksp Klin Farmakol; 1992; 55(6):24-6. PubMed ID: 1305868 [TBL] [Abstract][Full Text] [Related]
40. [About cavinton therapy of the patients with brain vascular diseases]. Nikitina VV; Pravdina AN; Zapatrina OV Voen Med Zh; 2007 Feb; 328(2):43-5. PubMed ID: 17508611 [No Abstract] [Full Text] [Related] [Previous] [Next] [New Search]